There have been 50 recent insider transactions recorded for Iterum Therapeutics plc (ITRM), including 19 buys and 28 sells. Total insider buying was valued at $836.42K and total insider selling at $559.53K.
Notable insiders with recent activity include Dunne Michael W., Coyne Christine, Whalen Joseph John. Insider transactions can provide insights into how company leadership views the stock's valuation and future prospects.
Insider Transactions — ITRM
| Date |
Name |
Role |
Transaction |
Shares |
Avg. Price |
Value |
Shares Owned |
| 2025-11-18 |
Dunne Michael W. |
Director |
Informative Buy |
6,000 |
$0.37 |
$2.19K |
241,001 |
| 2025-08-08 |
Dunne Michael W. |
Director |
Informative Buy |
15,000 |
$0.72 |
$10.85K |
235,001 |
| 2025-07-01 |
Coyne Christine |
Officer |
Unknown |
- |
- |
- |
- |
| 2025-07-01 |
Coyne Christine |
Chief Commercial Officer |
RSU Award |
200,000 |
$0.97 |
$194K |
200,000 |
| 2025-03-10 |
Whalen Joseph John |
Officer |
Unknown |
- |
- |
- |
- |
| 2025-01-13 |
Hunt Ronald |
Director |
Other (Sell) |
- |
- |
- |
- |
| 2024-08-06 |
Hunt Ronald |
Director |
Option Exercise (Sell) |
130,962 |
$0.61 |
$79.89K |
- |
| 2024-08-06 |
Dunne Michael W. |
Director |
Option Exercise (Sell) |
212,494 |
$0.61 |
$129.62K |
- |
| 2024-08-06 |
Fishman Corey N. |
Chief Executive Officer |
Option Exercise (Sell) |
165,226 |
$0.61 |
$100.79K |
- |
| 2023-12-22 |
Dunne Michael W. |
Director |
Informative Buy |
25,000 |
$1.40 |
$35K |
113,754 |
| 2023-12-18 |
Dunne Michael W. |
Director |
Informative Buy |
10,000 |
$1.84 |
$18.44K |
88,754 |
| 2023-12-01 |
Puttagunta Sailaja |
Chief Medical Officer |
Tax Withholding of RSU |
2,933 |
$2.12 |
$6.22K |
10,369 |
| 2023-11-22 |
Dunne Michael W. |
Director |
Informative Buy |
20,000 |
$2.03 |
$40.69K |
78,754 |
| 2023-11-20 |
Fishman Corey N. |
Chief Executive Officer |
Informative Buy |
10,000 |
$1.59 |
$15.86K |
54,449 |
| 2023-10-01 |
Hunt Ronald |
Director |
Option Exercise (Sell) |
5,479 |
- |
- |
- |
| 2023-10-01 |
Dunne Michael W. |
Director |
Option Exercise (Sell) |
3,487 |
- |
- |
- |
| 2023-07-01 |
Hunt Ronald |
Director |
Option Exercise (Sell) |
2,796 |
- |
- |
- |
| 2023-07-01 |
Dunne Michael W. |
Director |
Option Exercise (Sell) |
1,779 |
- |
- |
- |
| 2023-06-15 |
Dunne Michael W. |
Director |
Option Exercise (Sell) |
15,853 |
- |
- |
- |
| 2023-06-15 |
Hecht Beth |
Director |
Option Exercise (Sell) |
15,853 |
- |
- |
- |
| 2023-06-15 |
Chin Mark |
Director |
Option Exercise (Sell) |
15,853 |
- |
- |
- |
| 2023-04-01 |
Hunt Ronald |
Director |
Option Exercise (Sell) |
2,041 |
- |
- |
- |
| 2023-04-01 |
Dunne Michael W. |
Director |
Option Exercise (Sell) |
1,299 |
- |
- |
- |
| 2023-04-01 |
Dunne Michael W. |
Director |
Option Exercise |
1,299 |
- |
- |
37,635 |
| 2023-03-31 |
Fishman Corey N. |
Chief Executive Officer |
RSU Award |
275,000 |
$1.00 |
$275K |
275,000 |
| 2023-03-31 |
Matthews Judith M. |
Chief Financial Officer |
RSU Award |
100,000 |
$1.00 |
$100K |
100,000 |
| 2023-03-31 |
Puttagunta Sailaja |
Chief Medical Officer |
RSU Award |
75,000 |
$1.00 |
$75K |
75,000 |
| 2023-03-11 |
Fishman Corey N. |
Chief Executive Officer |
Option Exercise (Sell) |
14,333 |
- |
- |
- |
| 2023-03-11 |
Matthews Judith M. |
Chief Financial Officer |
Option Exercise (Sell) |
6,666 |
- |
- |
- |
| 2023-01-01 |
Hunt Ronald |
Director |
Option Exercise (Sell) |
1,197 |
- |
- |
- |
| 2023-01-01 |
Dunne Michael W. |
Director |
Option Exercise (Sell) |
761 |
- |
- |
- |
| 2022-12-23 |
Hunt Ronald |
Director |
RSU Award |
5,479 |
- |
- |
5,479 |
| 2022-12-23 |
Ahrens Brenton Karl |
Director |
RSU Award |
29,125 |
$0.81 |
$23.59K |
29,125 |
| 2022-12-23 |
Dunne Michael W. |
Director |
RSU Award |
3,487 |
- |
- |
3,487 |
| 2022-12-02 |
Puttagunta Sailaja |
Chief Medical Officer |
Informative Sell |
3,365 |
$1.32 |
$4.44K |
4,969 |
| 2022-12-01 |
Puttagunta Sailaja |
Chief Medical Officer |
RSU Award |
8,334 |
- |
- |
8,334 |
| 2022-09-25 |
Hunt Ronald |
Director |
RSU Award |
2,796 |
- |
- |
2,796 |
| 2022-09-25 |
Dunne Michael W. |
Director |
RSU Award |
1,779 |
- |
- |
1,779 |
| 2022-09-25 |
Ahrens Brenton Karl |
Director |
RSU Award |
14,838 |
$1.59 |
$23.59K |
14,838 |
| 2022-09-20 |
Ahrens Brenton Karl |
Director |
Informative Sell |
7,246 |
$1.78 |
$12.91K |
- |
| 2022-09-19 |
Ahrens Brenton Karl |
Director |
Informative Sell |
15,000 |
$1.77 |
$26.48K |
7,246 |
| 2022-09-16 |
Ahrens Brenton Karl |
Director |
Informative Sell |
15,000 |
$1.90 |
$28.54K |
22,246 |
| 2022-09-15 |
Ahrens Brenton Karl |
Director |
Informative Sell |
15,000 |
$2.02 |
$30.27K |
37,246 |
| 2022-09-14 |
Ahrens Brenton Karl |
Director |
Informative Sell |
15,000 |
$2.10 |
$31.46K |
52,246 |
| 2022-09-13 |
Ahrens Brenton Karl |
Director |
Informative Sell |
15,000 |
$2.14 |
$32.12K |
67,246 |
| 2022-09-12 |
Ahrens Brenton Karl |
Director |
Informative Sell |
15,000 |
$2.31 |
$34.61K |
82,246 |
| 2022-09-09 |
Ahrens Brenton Karl |
Director |
Informative Sell |
15,000 |
$2.32 |
$34.73K |
97,246 |
| 2022-09-08 |
Ahrens Brenton Karl |
Director |
Informative Sell |
3,298 |
$2.26 |
$7.47K |
112,246 |
| 2022-09-07 |
Dunne Michael W. |
Director |
Informative Buy |
10,000 |
$2.22 |
$22.2K |
35,576 |
| 2022-09-07 |
Dunne Michael W. |
Director |
Unknown |
- |
- |
- |
- |
■ Informative Buy/Sell — open market transaction (most significant)
■ Uninformative Buy — award, option exercise, conversion
■ Uninformative Sell — tax withholding, award vest sale
■ Neutral — gift, trust, expiry
